Tag: enoxaparin

Click to read the study in NEJM ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...

1. In this randomized clinical trial, there were no differences in mortality, pulmonary embolism, or safety between thromboprophylaxis with aspirin ...

  1. In this random1. In this randomized controlled trial that included 9711 patients undergoing hip or knee arthroplasty, treatment ...

 1. Routine use of prophylactic twice-daily enoxaparin demonstrated adequate safety in children with acute COVID-19 and multisystem inflammatory syndrome in children ...

In a group of hospitalized COVID-19 patients, a therapeutic dose of low-molecular-weight heparin reduced major thromboembolic events and death. Evidence ...

1. Therapeutic anticoagulation with rivaroxaban or enoxaparin did not improve clinical outcomes and increased bleeding compared with prophylactic anticoagulation. 2. ...

1. For patients who underwent elective surgery and were at moderate to high risk of venous thromboembolism, pharmaco-thromboprophylaxis with low ...

Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: ...

1. Anticoagulation at prophylactic dosing appeared to be associated with lower mortality and better prognosis in COVID-19 patients with coagulation dysfunction: ...

1. Anticoagulation at prophylactic dosing appeared to be associated with lower mortality and better prognosis in COVID-19 patients with coagulation ...